• Thurs news: Novartis not joining weight loss race. Pharma marketing and climate change. Roche flu treatment trial. Cercle’s fund raise for women’s health. ICER looks at GSK COPD drugs. See more on our front page

Pfizer and Novartis Are Betting On This Under-the-Radar Biotech. Should You?

cafead

Administrator
Staff member
  • cafead   Mar 20, 2022 at 11:22: PM
via
  • Pfizer and Novartis have licensed Voyager's promising AAV capsid technology.
  • Voyager faces significant risks, especially with no candidates in clinical studies yet.
  • A wait-and-see approach is probably the best one for now with the biotech stock.

article source
 

<